Pharmaceutical Research

, Volume 10, Issue 10, pp 1411–1419 | Cite as

Microdialysis Calibration Using Retrodialysis and Zero-Net Flux: Application to a Study of the Distribution of Zidovudine to Rabbit Cerebrospinal Fluid and Thalamus

  • Yanfeng Wang
  • Shekman L. Wong
  • Ronald J. Sawchuk
Article

Abstract

A retrodialysis (RD) method for the real-time calibration of on-line microdialysis (MD) procedures was investigated in vitro and in vivo. Calibration by retrodialysis was simultaneously validated through the use of a zero-net flux (ZNF) method, which assumes directional independence of diffusion of the solute. In RD, a calibrator with dialysance (PeA; effective permeability–surface area product) similar to that of the compound of interest is introduced into the perfusate. If the calibrator is suitable, its loss from the perfusate during RD is identical to the recovery of the solute of interest determined simultaneously by normal MD. Two antiviral nucleosides (AZT and AZdU) which differ structurally by only a methylene group were utilized as solute and calibrator, respectively. Both nucleosides exhibited similar recovery and loss at flow rates of 0.5 to 5 (µL/min in vitro, indicating a similar PeA product in this flow domain. Furthermore, both compounds showed similar loss into the lateral ventricle or thalamus of rabbits (n = 4) during RD at a flow rate of 1 µL/min for 6 hr. The relative loss decreased rapidly within the first hour, reaching a relatively stable value after 2 hr. The significant reduction in the loss of AZdU and AZT in vivo compared with that in vitro likely results from a lower diffusion coefficient in tissue. The distribution of AZT between plasma and cerebrospinal fluid (CSF) in the ventricle and extracellular fluid (ECF) in thalamus was determined at steady state using calibration by RD and ZNF simultaneously. The relative loss of AZdU during continuous RD was not significantly different from the recovery of AZT determined by ZNF in the same animal. Since RD may allow for continuous monitoring of microdialysis recovery in real time, it may offer an advantage over the ZNF method of system calibration. The steady-state Ccsf/Cp and Cecf/Cp ratios for AZT in this study were 0.26 ± 0.08 and 0.18 ± 0.08. That these ratios are much less than unity suggests that carrier-mediated transport of AZT exists in the brain-to-plasma direction.

brain microdialysis retrodialysis zero-net flux antiviral nucleosides 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    L. Bito, H. Davson, L. M. Murray, and N. Snider. The concentrations of free amino acids and other electrolytes in cerebrospinal fluid, in vivo dialysate of brain, and blood plasma of dog. J. Neurochem. 13:1056–1067 (1966).Google Scholar
  2. 2.
    U. Ungerstedt and C. Pycock. Functional correlates of dopamine neurotransmission. Bull. Schweiz. Akad. Med. Wiss. 1278:1–13 (1974).Google Scholar
  3. 3.
    L. Stahle, S. Segersvard, and U. Ungerstedt. Theophylline concentration in the extracellular space of the rat brain: Measurement by microdialysis and relation to behavior. Eur. J. Pharmacol. 185:187–193 (1990).Google Scholar
  4. 4.
    P. F. Morrison, P. M. Bungay, J. K. Hsiao, B. A. Ball, I. N. Mefford, and R. L. Dedrick. Quantitative microdialysis: Analysis of transients and application to pharmacokinetics in brain. J. Neurochem. 57:103–119 (1991).Google Scholar
  5. 5.
    S. L. Wong, Y. Wang, and R. J. Sawchuk. Analysis of zidovudine distribution to specific regions in rabbit brain using microdialysis. Pharm. Res. 9:332–338 (1992).Google Scholar
  6. 6.
    P. Lonnroth, P. A. Jansson, and U. Smith. A microdialysis method allowing characterization of intercellular water space in humans. Am. J. Physio. 253:E228–231 (1987).Google Scholar
  7. 7.
    R. A. Yokel, D. D. Allen, D. E. Burgio, and P. J. McNamara. Antipyrine as a dialyzable reference to correct differences in efficiency among and within sampling devices during in vivo microdialysis. J. Pharmacol. Toxicol. Meth. 27:135–142 (1992).Google Scholar
  8. 8.
    D. O. Scott, L. R. Sorenson, K. L. Steele, D. L. Puckett, and C. E. Lunte. In vivo microdialysis sampling for pharmacokinetic investigations. Pharm. Res. 8:389–392 (1991).Google Scholar
  9. 9.
    A. M. Herrera, D. O. Scott, and C. E. Lunte. Microdialysis sampling for determination of plasma protein binding of drugs. Pharm. Res. 7:1077–1081 (1990).Google Scholar
  10. 10.
    N. Lindefors, G. Amberg, and U. Ungerstedt. Intracerebral microdialysis. I. Experimental studies of diffusion kinetics. J. Pharmacol. Meth. 22:141–156 (1989).Google Scholar
  11. 11.
    G. Amberg and N. Lindefors. Intracerebral microdialysis. II. Mathematical studies of diffusion kinetics. J. Pharmacol. Meth. 22:157–183 (1989).Google Scholar
  12. 12.
    P. M. Bungay, P. F. Morrison, and R. L. Dedrick. Steady state theory for quantitative microdialysis of solutes and water in vivo and in vitro. Life Sci. 46:105–119 (1990).Google Scholar
  13. 13.
    I. Jacobson, M. Sanderg, and A. Hamberger. Mass transfer in brain dialysis devices: A new method for the estimation of extracellular amino acids concentration. J. Neurosci. Meth. 15:263–268 (1985).Google Scholar

Copyright information

© Plenum Publishing Corporation 1993

Authors and Affiliations

  • Yanfeng Wang
    • 1
  • Shekman L. Wong
    • 1
  • Ronald J. Sawchuk
    • 1
  1. 1.Department of Pharmaceutics, College of PharmacyUniversity of MinnesotaMinneapolis

Personalised recommendations